Rabies vaccine shedule new guidelines

Reading File
Searching the Web

rabies vaccine schedule new guidelines 2024 2025

Finding Sources
Reading Web Page

rabies vaccine schedule pre-exposure post-exposure guidelines 2024 2025

Reading File
Searching the Web

CDC rabies pre-exposure prophylaxis PrEP schedule 2024 updated 2-dose

I now have comprehensive information to give a detailed, up-to-date answer. Here is the full guide:

Rabies Vaccine Schedule - Current Guidelines (2025/2026)

Key Update: PrEP Changed to 2 Doses (ACIP 2022, in effect)

The most significant recent change: In May 2022, the CDC's Advisory Committee on Immunization Practices (ACIP) reduced the pre-exposure prophylaxis (PrEP) primary series from 3 doses to 2 doses. This remains the current standard.

1. Pre-Exposure Prophylaxis (PrEP)

For people at elevated risk before any exposure (veterinarians, animal handlers, bat cave explorers, lab workers, travelers to endemic areas).

Primary Series (Updated - 2 Doses for Immunocompetent Adults ≥18 yrs)

DayDose
Day 01.0 mL IM (deltoid)
Day 71.0 mL IM (deltoid)
The 2-dose schedule replaces the old 3-dose series (Days 0, 7, 21/28). It provides equivalent protection for up to 3 years.

ACIP Risk Category Tiers for PrEP

Risk CategoryWho It CoversRecommendation
1 - HighestLab workers with live/concentrated rabies virus2 doses + periodic titer checks + boosters as needed
2Frequent bat handlers, spelunkers, animal necropsies2 doses + periodic titer monitoring
3Contact with potentially rabid non-bat mammals, >3 years after PrEP2 doses (Days 0 & 7) + titer or booster after 3 years
4Same as Cat. 3, but ≤3 years after PrEP2 doses (Days 0 & 7)
5 - LowestGeneral U.S. populationNot recommended routinely

Booster Policy

  • Categories 1 & 2: Periodic serology (titer testing) to confirm immunity; booster if titer falls below acceptable level.
  • Category 3: Titer check or booster after 3 years from primary series.
  • Category 4: No booster needed within 3 years if primary series was completed.

2. Post-Exposure Prophylaxis (PEP)

Step 1 - Immediate Wound Care (ALL patients)

  • Wash thoroughly with soap and water for at least 15 minutes.
  • Use a virucidal agent (e.g., povidone-iodine) if available.
  • This single step can reduce viral load by up to 90%.

Scenario A: Never Vaccinated (Unimmunized)

DayTreatment
Day 0HRIG (20 IU/kg body weight) infiltrated around wound + 1st vaccine dose at separate site
Day 3Vaccine dose 2
Day 7Vaccine dose 3
Day 14Vaccine dose 4 (final for immunocompetent)
Day 28Vaccine dose 5 (only for immunocompromised patients)
  • Vaccine: HDCV or PCECV, 1.0 mL IM in deltoid (thigh for small children).
  • Do NOT inject in the gluteal area (reduced immunogenicity).
  • HRIG and first vaccine dose must NEVER be given in the same syringe or anatomical site.
  • HRIG is given only once - it bridges immunity until the vaccine kicks in.

Scenario B: Previously Vaccinated (Booster PEP)

DayTreatment
Day 0Vaccine dose 1 (no HRIG)
Day 3Vaccine dose 2
  • No HRIG is needed - prior vaccination provides memory immunity.
  • Only 2 doses of vaccine total.
"Previously vaccinated" = completed a recognized PrEP or PEP series. If vaccination status is uncertain or incomplete, treat as unvaccinated.

Scenario C: Immunocompromised Patients

DayTreatment
Day 0HRIG + Vaccine dose 1
Day 3Vaccine dose 2
Day 7Vaccine dose 3
Day 14Vaccine dose 4
Day 28Vaccine dose 5
  • Check rabies virus neutralizing antibody titer 7-14 days after final dose.
  • Avoid immunosuppressive drugs during PEP unless absolutely necessary.

3. Available Vaccine Types

VaccineAbbreviationNotes
Human Diploid Cell VaccineHDCV (Imovax)IM only
Purified Chick Embryo Cell VaccinePCECV (RabAvert)IM only
Both are interchangeable in terms of schedule and dosing.

4. Special Notes

  • Pregnancy: NOT a contraindication for PEP. Exposure to rabies does not require pregnancy termination.
  • Infants/Children: PEP is suitable for all ages. Use anterolateral thigh for small children.
  • No known contraindications for rabies vaccination in PEP setting.
  • Intradermal (ID) route: WHO allows ID administration in resource-limited settings (ID PEP schedules exist - see WHO 2018 position paper), but CDC/US guidelines are IM-only.
  • If PEP was started outside the U.S., CDC recommends completing the series and may require serologic testing depending on the regimen used.

Summary Quick Reference

SituationHRIGVaccine DosesDays
PrEP (immunocompetent)No20, 7
PEP - unvaccinated (immunocompetent)Yes (Day 0)40, 3, 7, 14
PEP - unvaccinated (immunocompromised)Yes (Day 0)50, 3, 7, 14, 28
PEP - previously vaccinatedNo20, 3

Sources: CDC PEP Guidance | CDC PrEP Guidance | ACIP 2-dose PrEP recommendation | Goodman & Gilman's Pharmacological Basis of Therapeutics
This is a shared conversation. Sign in to Orris to start your own chat.